Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ascentage, Ascletis, Astellas, Bristol-Myers Squibb, Roche, Seattle Genetics, Seqirus, Takeda.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Eisai, Harbour Biomed, Immutep, Isofol Medical, Kowa Research Institute, Molecular Templates, Ribomic, Zelira.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altair Medical, Asuragen, Avanos Medical, Cynosure, Emagine Solutions Technology, Emcyte, Fujifilm, Kurin, Zynex.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adchim, Advion, American Brivision, Analog Devices, Artizan Biosciences, Beijing Bohui Innovation Biotechnology, Biomatrix, Bwx Technologies Certara, Cove, Ekso Bionics, Gerpang Healthcare Group, Gn Hearing, In Silico Biosciences, Interchim, International Health Technologies, Kindred Healthcare, Masimo, Miroculus, Milestone Scientific, Mologic, Ms Westfalia, Natus, Nemaura Medical, Pinpoint Science, Red One Medical, Redox, Resound, Siemens Healthineers, Theranica Bioelectronics, Trianni, Twist Bioscience, Welldoc.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genentech, Halozyme, Lysogene, Noxopharm.